Related Experiment Video
Updated: Feb 11, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
[Overweight and obesity in children treated for congenital heart disease]
Francesca Perin1, Carmen Carreras Blesa1, Maria Del Mar Rodríguez Vázquez Del Rey1
1Unidad de Cardiología Infantil, Servicio de Pediatría, Hospital Universitario Virgen de las Nieves, Granada, España.
Insights
Obesity is common in children with congenital heart disease (CHD) and linked to high blood pressure. Early prevention and treatment of overweight and obesity are crucial for this vulnerable group.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Health
- Pediatric Endocrinology
Background:
- Overweight and obesity pose greater risks for children with congenital heart disease (CHD).
- This study investigates the prevalence of overweight/obesity and systolic arterial hypertension in children with CHD.
Purpose of the Study:
- To determine the proportion of overweight and obesity in children undergoing CHD intervention.
- To assess systolic arterial hypertension as an early cardiovascular complication in this population.
Main Methods:
- Retrospective analysis of 440 patients (6-17 years), including 220 with CHD and healthy controls.
- Calculation of body mass index (BMI) percentiles using WHO criteria.
- Review of anthropometric data, clinical data, and systolic blood pressure (SBP).
Main Results:
- Obesity prevalence (BMI percentile ≥97) was higher in CHD patients (22.7%) than controls (15.5%).
- Overweight/obesity (BMI percentile ≥85) affected 35.4% of CHD patients and 37.3% of controls.
- Elevated SBP (≥95th percentile) was significantly more common in overweight CHD patients (29.5%) versus normal-weight (7.7%).
Conclusions:
- High obesity rates are observed in children treated for CHD.
- Obesity in these children is associated with elevated systolic blood pressure levels.
- Preventive strategies and obesity management are essential to mitigate long-term complications in this vulnerable pediatric population.
Introduction:
The negative impact of overweight and obesity is potentially greater in children affected by a congenital heart disease (CHD). The aim of this study is to calculate the proportion of overweight and obesity in children who underwent an intervention for CHD, and to investigate systolic arterial hypertension as a possible early cardiovascular complication.
Patients And Methods:
A retrospective study was conducted on patients aged 6-17 years treated for CHD, and healthy control subjects, followed-up in a Paediatric Cardiology Clinic. Body mass index percentiles were calculated according to the criteria of WHO. A review was performed on the anthropometric and clinical data, as well as the systolic blood pressure (SBP).
Results:
A total of 440 patients were included, of which 220 had CHD. The proportion of combined obesity and overweight (body mass index percentile ≥85) was 36.4% (37.3% in healthy subjects and 35.4% in patients with CHD, P=.738). A higher prevalence of obesity (body mass index percentile ≥97) was found in CHD patients (22.7%) compared to 15.5% in healthy subjects (P=.015). SBP percentiles were higher in overweight compared to normal-weight patients (P < .001). The prevalence of SBP readings ≥ the 95th percentile was greater in overweight than in normal weight CHD patients (29.5% versus 7.7%, P < .001) and also in the overweight healthy controls compared to those of normal weight (12.2% versus 0.7%, P < .001).
Conclusions:
The proportion of obesity is high in children treated for CHD and it is associated with elevated SBP levels. The risk of long-term complications needs to be reduced by means of prevention and treatment of obesity in this vulnerable population.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Obesity
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

